NCT05186597View on ClinicalTrials.gov

Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection

UnknownOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

July 14, 2024

Study Completion Date

December 31, 2024

Conditions

SARS CoV 2 InfectionMultisystem Inflammatory Disease, Pediatric, COVID-19 RelatedMultisystem Inflammatory Syndrome in ChildrenCOVID-19 Pandemic

Trial Locations (1)

2100

RECRUITING

Copenhagen University Hospital Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

Innovation Fund Denmark

All Listed Sponsors

collaborator

Innovation Fund Denmark

INDIV

collaborator

Ministry of Education, Denmark

OTHER_GOV

lead

Rigshospitalet, Denmark

OTHER